Cultured stem cells as tools for toxicological assays

Journal of Bioscience and Bioengineering

Volumn 116, Issue 6, 2013, Pages 647-652

  Mori, Hideki ^a   Hara, Masayuki ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Developmental toxicity; Embryonic stem cell; Heavy metal; Neural stem cell; Safety assessment

Indexed keywords

ALTERNATIVE ASSESSMENT; CELL CULTURE TECHNIQUES; DEVELOPMENTAL TOXICITY; EMBRYONIC STEM CELLS; ETHICAL CONSIDERATIONS; NEURAL STEM CELL; SAFETY ASSESSMENTS; TOXIC SUBSTANCES;

CELL CULTURE; CELL GROWTH; HEAVY METALS; MAMMALS; SAFETY TESTING; TOXICITY;

STEM CELLS;

BIOMATERIAL; CADMIUM; DRUG CARRIER; HEAVY METAL; LEAD; MERCURY; METAL; METAL ION; PAINT; REACTIVE OXYGEN METABOLITE; TOXIC SUBSTANCE; TRACE ELEMENT; XENOBIOTIC AGENT; ZINC;

ABSORPTION; ADULT STEM CELL; CELL ASSAY; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL MANIPULATION; CELL MEMBRANE; CELL PROLIFERATION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; CULTURE TECHNIQUE; CYTOTOXICITY; DEVELOPMENTAL DISORDER; DEVELOPMENTAL TOXICITY; DIGESTION; ELECTRONICS; EMBRYO CULTURE; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXPERIMENTAL ANIMAL; FETUS DEVELOPMENT; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; LEAD POISONING; MAMMAL CELL; MEDICAL DEVICE; METABOLISM; MICROSCOPY; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; QUALITY CONTROL; REVIEW; SAFETY; STEM CELL; STEM CELL CULTURE; TERATOGENICITY; TOXICOLOGY; VASCULAR TISSUE;

MAMMALIA;

DEVELOPMENTAL TOXICITY; EMBRYONIC STEM CELL; HEAVY METAL; NEURAL STEM CELL; SAFETY ASSESSMENT;

ADULT STEM CELLS; ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EMBRYONIC STEM CELLS; HUMANS; METALS, HEAVY; TOXICITY TESTS;

EID: 84886445870     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2013.05.028     Document Type: Review

References (70)

1. Svendsen C.N., ter Borg M.G., Armstrong R.J., Rosser A.E., Chandran S., Ostenfeld T., Caldwell M.A. Anew method for the rapid and long term growth of human neural precursor cells. J.Neurosci. Methods 1998, 85:141-152.
2. Kanemura Y., Mori H., Kobayashi S., Islam O., Kodama E., Yamamoto A., Nakanishi Y., Arita N., Yamasaki M., Okano H., Hara M., Miyake J. Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J.Neurosci. Res. 2002, 69:869-879.
3. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
4. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
5. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
6. Watanabe K., Ueno M., Kamiya D., Nishiyama A., Matsumura M., Wataya T., Takahashi J.B., Nishikawa S., Muguruma K., Sasai Y. AROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 2007, 25:681-686.
7. Brown N.A. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods. Altern. Lab. Anim. 2002, 30:177-198.
8. Stummann T.C., Bremer S. Embryonic stem cells in safety pharmacology and toxicology. Adv. Exp. Med. Biol. 2012, 745:14-25.
9. Seiler A.E., Spielmann H. The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat. Protoc. 2011, 6:961-978.
10. Seiler A., Visan A., Buesen R., Genschow E., Spielmann H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol. 2004, 18:231-240.
11. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
12. Hubner K., Fuhrmann G., Christenson L.K., Kehler J., Reinbold R., De La Fuente R., Wood J., Strauss J.F., Boiani M., Scholer H.R. Derivation of oocytes from mouse embryonic stem cells. Science 2003, 300:1251-1256.
13. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah O., Itskovitz-Eldor J., Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J.Clin. Invest. 2001, 108:407-414.
14. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., Hoskins E.E., Kalinichenko V.V., Wells S.I., Zorn A.M., Shroyer N.F., Wells J.M. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470:105-109.
15. Li W., Sun W., Zhang Y., Wei W., Ambasudhan R., Xia P., Talantova M., Lin T., Kim J., Wang X., other 4 authors Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc. Natl. Acad. Sci. USA 2011, 108:8299-8304.
16. Cheng X., Ying L., Lu L., Galvao A.M., Mills J.A., Lin H.C., Kotton D.N., Shen S.S., Nostro M.C., Choi J.K., other 3 authors Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell 2012, 10:371-384.
17. McNeish J. Embryonic stem cells in drug discovery. Nat. Rev. Drug Discov. 2004, 3:70-80.
18. Cotovio J., Grandidier M.H., Lelievre D., Bremond C., Amsellem C., Maloug S., Ovigne J.M., Loisel-Joubert S., Van Der Lee A., Minondo A., other 7 authors In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic (TM) HCE model: application to 435 substances from consumer products industry. Toxicol. In Vitro 2010, 24:523-537.
19. Issa Y., Watts D.C., Duxbury A.J., Brunton P.A., Watson M.B., Waters C.M. Mercuric chloride: toxicity and apoptosis in a human oligodendroglial cell line MO3.13. Biomaterials 2003, 24:981-987.
20. Yamamoto A., Honma R., Sumita M. Cytotoxicity evaluation of 43 metal salts using murine fibroblasts and osteoblastic cells. J.Biomed. Mater. Res. 1998, 39:331-340.
21. Spielmann H., Balls M., Brand M., Doring B., Holzhutter H.G., Kalweit S., Klecak G., Eplattenier H.L., Liebsch M., Lovell W.W., other 9 authors EEC/COLIPA project on in vitro phototoxicity testing - first results obtained with a Balb/C 3T3 cell phototoxicity assay. Toxicol. In Vitro 1994, 8:793-796.
22. Fernandes M.B., Goncalves J.E., Scotti M.T., de Oliveira A.A., Tavares L.C., Storpirtis S. Caco-2 cells cytotoxicity of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA). Toxicol. In Vitro 2012, 26:535-540.
23. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 2001, 7:1028-1034.
24. Scanu M., Mancuso L., Cao G. Evaluation of the use of human mesenchymal stem cells for acute toxicity tests. Toxicol. In Vitro 2011, 25:1989-1995.
25. Stummann T.C., Hareng L., Bremer S. Hazard assessment of methylmercury toxicity to neuronal induction in embryogenesis using human embryonic stem cells. Toxicology 2009, 257:117-126.
26. Genschow E., Spielmann H., Scholz G., Seiler A., Brown N., Piersma A., Brady M., Clemann N., Huuskonen H., Paillard F., Bremer S., Becker K. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. Altern. Lab. Anim. 2002, 30:151-176.
27. Spielmann H., Grune B., Liebsch M., Seiler A., Vogel R. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment). Exp. Toxicol. Pathol. 2008, 60:225-233.
28. Breier J.M., Gassmann K., Kayser R., Stegeman H., De Groot D., Fritsche E., Shafer T.J. Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol. 2010, 32:4-15.
29. Chang J.K., Li C.J., Wu S.C., Yeh C.H., Chen C.H., Fu Y.C., Wang G.J., Ho M.L. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem. Pharmacol. 2007, 74:1371-1382.
30. Hackenberg S., Scherzed A., Kessler M., Hummel S., Technau A., Froelich K., Ginzkey C., Koehler C., Hagen R., Kleinsasser N. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol. Lett. 2011, 201:27-33.
31. Kermani S., Karbalaie K., Madani S.H., Jahangirnejad A.A., Eslaminejad M.B., Nasr-Esfahani M.H., Baharvand H. Effect of lead on proliferation and neural differentiation of mouse bone marrow-mesenchymal stem cells. Toxicol. In Vitro 2008, 22:995-1001.
32. Moors M., Rockel T.D., Abel J., Cline J.E., Gassmann K., Schreiber T., Schuwald J., Weinmann N., Fritsche E. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect. 2009, 117:1131-1138.
33. Castoldi A.F., Onishchenko N., Johansson C., Coccini T., Roda E., Vahter M., Ceccatelli S., Manzo L. Neurodevelopmental toxicity of methylmercury: laboratory animal data and their contribution to human risk assessment. Regul. Toxicol. Pharmacol. 2008, 51:215-229.
34. Tamm C., Duckworth J., Hermanson O., Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J.Neurochem. 2006, 97:69-78.
35. Gassmann K., Baumann J., Giersiefer S., Schuwald J., Schreiber T., Merk H.F., Fritsche E. Automated neurosphere sorting and plating by the COPAS large particle sorter is a suitable method for high-throughput 3D in vitro applications. Toxicol. In Vitro 2012, 26:993-1000.
36. Stummann T.C., Hareng L., Bremer S. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells. Toxicology 2007, 242:130-143.
37. Stummann T.C., Hareng L., Bremer S. Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells. Toxicology 2008, 252:118-122.
38. Zimmer B., Schildknecht S., Kuegler P.B., Tanavde V., Kadereit S., Leist M. Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. Toxicol. Sci. 2011, 121:357-367.
39. Adler S., Basketter D., Creton S., Pelkonen O., van Benthem J., Zuang V., Andersen K.E., Angers-Loustau A., Aptula A., Bal-Price A., other 45 authors Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch. Toxicol. 2011, 85:367-485.
40. Bhogal N., Grindon C., Combes R., Balls M. Toxicity testing: creating a revolution based on new technologies. Trends Biotechnol. 2005, 23:299-307.
41. Kang K.S., Trosko J.E. Stem cells in toxicology: fundamental biology and practical considerations. Toxicol. Sci. 2011, 120:S269-S289.
42. Trosko J.E., Chang C.C. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment. Toxicology 2010, 270:18-34.
43. Theunissen P.T., Robinson J.F., Pennings J.L., van Herwijnen M.H., Kleinjans J.C., Piersma A.H. Compound-specific effects of diverse neurodevelopmental toxicants on global gene expression in the neural embryonic stem cell test (ESTn). Toxicol. Appl. Pharmacol. 2012, 262:330-340.
44. Baek D.H., Kim T.G., Lim H.K., Kang J.W., Seong S.K., Choi S.E., Lim S.Y., Park S.H., Nam B.H., Kim E.H., Kim M.S., Park K.L. Embryotoxicity assessment of developmental neurotoxicants using a neuronal endpoint in the embryonic stem cell test. J.Appl. Toxicol. 2012, 32:617-626.
45. Takayama K., Inamura M., Kawabata K., Sugawara M., Kikuchi K., Higuchi M., Nagamoto Y., Watanabe H., Tashiro K., Sakurai F., other 3 authors Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1alpha transduction. J.Hepatol. 2012, 57:628-636.
46. Duan Y., Ma X., Zou W., Wang C., Bahbahan I.S., Ahuja T.P., Tolstikov V., Zern M.A. Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells 2010, 28:674-686.
47. Yokoo N., Baba S., Kaichi S., Niwa A., Mima T., Doi H., Yamanaka S., Nakahata T., Heike T. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 2009, 387:482-488.
48. Yamazaki K., Hihara T., Taniguchi T., Kohmura N., Yoshinaga T., Ito M., Sawada K. Anovel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval. Toxicol. In Vitro 2012, 26:335-342.
49. Yla-Outinen L., Heikkila J., Skottman H., Suuronen R., Aanismaa R., Narkilahti S. Human cell-based micro electrode array platform for studying neurotoxicity. Front. Neuroeng. 2010, 3:111.
50. Eiraku M., Watanabe K., Matsuo-Takasaki M., Kawada M., Yonemura S., Matsumura M., Wataya T., Nishiyama A., Muguruma K., Sasai Y. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 2008, 3:519-532.
51. Hogberg H.T., Sobanski T., Novellino A., Whelan M., Weiss D.G., Bal-Price A.K. Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons. Neurotoxicology 2011, 32:158-168.
52. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
53. Jarup L. Hazards of heavy metal contamination. Br. Med. Bull. 2003, 68:167-182.
54. Lin G.Z., Peng R.F., Chen Q., Wu Z.G., Du L. Lead in housing paints: an exposure source still not taken seriously for children lead poisoning in China. Environ. Res. 2009, 109:1-5.
55. Paoliello M.M., De Capitani E.M. Occupational and environmental human lead exposure in Brazil. Environ. Res. 2007, 103:288-297.
56. Rodin S., Domogatskaya A., Strom S., Hansson E.M., Chien K.R., Inzunza J., Hovatta O., Tryggvason K. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 2010, 28:611-615.
57. Kaur S., Singhal B. When nano meets stem: the impact of nanotechnology in stem cell biology. J.Biosci. Bioeng. 2012, 113:1-4.
58. Sakai Y., Yoshiura Y., Nakazawa K. Embryoid body culture of mouse embryonic stem cells using microwell and micropatterned chips. J.Biosci. Bioeng. 2011, 111:85-91.
59. Sakai Y., Yoshida S., Yoshiura Y., Mori R., Tamura T., Yahiro K., Mori H., Kanemura Y., Yamasaki M., Nakazawa K. Effect of microwell chip structure on cell microsphere production of various animal cells. J.Biosci. Bioeng. 2010, 110:223-229.
60. Cui Z.F., Xu X., Trainor N., Triffitt J.T., Urban J.P., Tirlapur U.K. Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing. Toxicol. In Vitro 2007, 21:1318-1324.
61. Takahashi S., Yamazoe H., Sassa F., Suzuki H., Fukuda J. Preparation of coculture system with three extracellular matrices using capillary force lithography and layer-by-layer deposition. J.Biosci. Bioeng. 2009, 108:544-550.
62. Okuyama T., Yamazoe H., Seto Y., Suzuki H., Fukuda J. Cell micropatterning inside a microchannel and assays under a stable concentration gradient. J.Biosci. Bioeng. 2010, 110:230-237.
63. Ni X.F., Crozatier C., Sensebe L., Langonne A., Wang L., Fan Y., He P.G., Chen Y. On-chip differentiation of human mesenchymal stem cells into adipocytes. Microelect. Eng. 2008, 85:1330-1333.
64. Groebe K., Hayess K., Klemm-Manns M., Schwall G., Wozny W., Steemans M., Peters A.K., Sastri C., Jaeckel P., Stegmann W., other 7 authors Protein biomarkers for in vitro testing of embryotoxicity. J.Proteome Res. 2010, 9:5727-5738.
65. Zimmer B., Kuegler P.B., Baudis B., Genewsky A., Tanavde V., Koh W., Tan B., Waldmann T., Kadereit S., Leist M. Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death Differ. 2011, 18:383-395.
66. Festag M., Viertel B., Steinberg P., Sehner C. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds. Toxicol. In Vitro 2007, 21:1631-1640.
67. Festag M., Sehner C., Steinberg P., Viertel B. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. I: establishment of the differentiation protocol. Toxicol. In Vitro 2007, 21:1619-1630.
68. Lim J.C., Wolpaw A.J., Caldwell M.A., Hladky S.B., Barrand M.A. Neural precursor cell influences on blood-brain barrier characteristics in rat brain endothelial cells. Brain Res. 2007, 1159:67-76.
69. Tsuda Y., Shimizu T., Yarnato M., Kikuchi A., Sasagawa T., Sekiya S., Kobayashi J., Chen G., Okano T. Cellular control of tissue architectures using a three-dimensional tissue fabrication technique. Biomaterials 2007, 28:4939-4946.
70. Kumar K.K., Aboud A.A., Bowman A.B. The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology 2012, 33:518-529.